Professional
Added to YB: 2025-01-16
Pitch date: 2025-01-15
DERM [bullish]
Journey Medical Corporation
+88.71%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$107.4M
Pitch Price
$3.81
Price Target
20.00 (+178%)
Dividend
N/A
Sector
Pharmaceuticals
Category
growth
Minot Light Capital Portfolio Holding: Journey Medical Corporation
DERM: Specialty pharma co. w/ $55-60M sales from existing portfolio. FDA approval for Emrosi (Rosacea) Nov 2024, potential $150-200M sales vs $300M for Oracea. 70% GM, no added salesforce. Trough valuation $4/share, upside $20/share (3x $150M 2027 rev or 15x $1.25 EPS). Current price $4.30, $91M mkt cap.
Read full article (2 min)